SCHEMBL6947753

SCHEMBL6947753

Cc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)n1C1CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.41
ALOX15 P16050 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OGFRL1 Q5TC84 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
HTT P42858 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PTPN11 Q06124 4/20 0.39
GRM2 Q14416 1/20 0.39
POLB P06746 2/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6951651 0.85 HPGD (0.43) ALDH1A1HPGDHTTKDM4EMEN1
SCHEMBL6949302 0.84 GRM2 (0.43) GAAALDH1A1HPGDHTTKDM4E
SCHEMBL6947212 0.83 HPGD (0.41) ALDH1A1HPGDHTTKDM4EMEN1
SCHEMBL6954345 0.83 GRM2 (0.41) ALDH1A1HPGDHTTKDM4EMEN1
SCHEMBL6952709 0.82 GRM2 (0.42) ALDH1A1HPGDHTTKDM4EMEN1
SCHEMBL6949656 0.81 GRM2 (0.41) GAAALDH1A1HPGDHTTKDM4E
SCHEMBL6951472 0.81 ALDH1A1 (0.47) ALDH1A1HPGDHTTKDM4EMEN1
SCHEMBL6945471 0.81 HPGD (0.42) ALDH1A1HPGDHTTKDM4EMEN1
SCHEMBL6947580 0.81 HPGD (0.40) GAAALDH1A1HPGDHTTKDM4E
SCHEMBL6949798 0.80 GRM2 (0.41) GAAALDH1A1HPGDHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed